The parameters of immune inflammation and haemostasis in patients with systemic lupus erythematosus (SLE) with antiphospholipid syndrome (APS) and without APS

被引:0
作者
Arshinov, A., V [1 ]
Emanuylov, V., I [1 ]
Zubova, N., V [1 ]
机构
[1] Yaroslavl State Med Acad, Rheumatol, Yaroslavl, Russia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PP-MO-260
引用
收藏
页码:406 / 406
页数:1
相关论文
共 50 条
  • [21] Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality
    Riancho-Zarrabeitia, Leyre
    Martinez-Taboada, Victor
    Rua-Figueroa, Inigo
    Alonso, Fernando
    Galindo-Izquierdo, Maria
    Ovalles, Juan
    Olive-Marques, Alejandro
    Fernandez-Nebro, Antonio
    Calvo-Alen, Jaime
    Menor-Almagro, Raul
    Tomero-Muriel, Eva
    Uriarte-Isacelaya, Esther
    Botenau, Alina
    Andres, Mariano
    Freire-Gonzalez, Mercedes
    Santos Soler, Gregorio
    Ruiz-Lucea, Esther
    Ibanez-Barcelo, Monica
    Castellvi, Ivan
    Galisteo, Carlos
    Quevedo Vila, Victor
    Raya, Enrique
    Narvaez-Garcia, Javier
    Exposito, Lorena
    Hernandez-Beriain, Jose A.
    Horcada, Loreto
    Aurrecoechea, Elena
    Pego-Reigosa, Jose M.
    LUPUS, 2020, 29 (12) : 1556 - 1565
  • [22] VENOUS THROMBOSIS IS MORE PREVALENT IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME (APS) ACCOMPANYING SYSTEMIC LUPUS ERYTHEMATOSUS, WHILE LIVEDO RETICULARIS IN PRIMARY APS
    Hatadyj, E. N.
    Wieczorek, A.
    Olesinska, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1224 - 1225
  • [23] Pulmonary involvement in asymptomatic systemic lupus erythematosus patients with antiphospholipid syndrome multislice CT angiography and pulmonary involvement in asymptomatic SLE patients with APS
    Gheita, T.
    Abo-Zeid, A.
    El-Fishawy, H.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2012, 61 (03): : 217 - 222
  • [24] Obstetric outcome in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS): St Thomas' Hospital lupus in pregnancy clinic experience.
    Khamashta, MA
    Buchanan, NMM
    Hughes, GRV
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1996, 89 (11): : 872 - 872
  • [25] Analysis of lethal outcomes in patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) based on long-term follow-up
    Reshetnyak, T. M.
    Shtivelband, I. B.
    Alexandrova, E. N.
    Mach, E. S.
    Kondratyeva, L., V
    Ostryakova, E., V
    Novikov, A. A.
    Nasonov, E. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 408 - 409
  • [26] SHOULD ANTIBODIES TO DOMAIN I B2-GLYCOPROTEIN 1 BE INVESTIGATED IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME (APS) AND SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)?
    Cheldieva, F.
    Reshetnyak, T.
    Cherkasova, M.
    Glukhova, S.
    Lila, A.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1374 - 1375
  • [27] Length of gestation in systemic lupus erythematosus (SLE) and the antiphospholipid syndrome (APS): Survival analysis of 282 pregnancies in 152 women.
    Buchanan, NMM
    Khamashta, MA
    Hughes, GRV
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S321 - S321
  • [28] ANTIPHOSPHOLIPID SYNDROME (APS) IN MALE LUPUS
    NASSONOV, EL
    ALEKBEROVA, ZA
    KLUKVINA, N
    ALEXANDROVA, EN
    SALOZHIN, KV
    LETONQUEZE, M
    YOUINOU, P
    NASSONOVA, VA
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 101 - 101
  • [29] MALIGNANT HYPERTENSION IN THE ANTIPHOSPHOLIPID SYNDROME (APS) WITHOUT LUPUS NEPHRITIS
    CACOUB, P
    PIETTE, JC
    BEAUFILS, H
    WECHSLER, B
    BLETRY, O
    HERREMAN, G
    GODEAU, P
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S360 - S360
  • [30] ANTIBODY TO DSDNA (ANTI-DSDNA), CIRCULATING IMMUNE COMPLEX (CIC) IN SYSTEMIC LUPUS ERITHEMATOSUS (SLE) AND ANTIPHOSPHOLIPID SYNDROME (APS)
    Reshetnyak, T.
    Alexandrova, E. N.
    Seredavkina, N. V.
    Verizhnikova, Z. G.
    Nasonov, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 921 - 921